Guidelines for the medical management of osteoarthritis

Arthritis & Rheumatism

Volumn 38, Issue 11, 1995, Pages 1535-1540

  Hochberg, Marc C ^a   Altman, Roy D ^b   Brandt, Kenneth D ^c   Clark, Bruce M ^d   Dieppe, Paul A ^e   Griffin, Marie R ^f   Moskowitz, Roland W ^g   Schnitzer, Thomas J ^h  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Mary Pack Arthritis Centre   (Canada)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CHOLINE MAGNESIUM TRISALICYLATE; CODEINE; CORTICOSTEROID; DEXTROPROPOXYPHENE; IBUPROFEN; INDOMETACIN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; SALSALATE;

ANALGESIA; ANIMAL MODEL; CORTICOSTEROID THERAPY; COXITIS; DRUG PREFERENCE; EXERCISE; GASTROINTESTINAL HEMORRHAGE; HIP DISEASE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; OBESITY; OCCUPATIONAL THERAPY; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PAIN; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOCIAL SUPPORT; TOTAL HIP PROSTHESIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HIP PROSTHESIS; HUMAN; INDIVIDUALITY; OSTEOARTHRITIS, HIP; PATIENT EDUCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0028806589     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780381103     Document Type: Article

References (40)

1. Arthritic and other musculoskeletal diseases
2. Osteoarthritis of the hip
3. Mechanical factors in articular cartilage and their role in osteoarthritis
4. Imbalances of anabolism and catabolism of cartilage matrix components in osteoarthritis
5. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip
6. Outcomes of self‐help education for patients with arthritis
7. Evidence suggesting that health education for self‐management in patients with chronic arthritis has sustained health benefits while reducing health care costs
8. Can the provision of information to patients with osteoarthritis improve functional status? A randomized, controlled trial
9. Cost‐effectiveness of increased telephone contact for patients with osteoarthritis: a randomized, controlled trial
10. Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis
11. Exercise in the management of osteoarthritis of the knee and hip
12. Biomechanical analysis of selected principles of hip joint protection
13. Influence of artificaial shock absorbers on human gait
14. Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis
15. Is there a role for diet or other questionable therapies in managing rheumatic diseases
16. Toward pharmacologic modification of joint damage in osteoarthritis
17. Principles of drug therapy
18. Should nonsteroidal anti‐inflammatory drugs be used to treat osteoarthritis
19. Paracetamol medication and alcohol abuse: a dangerous combination for the liver and the kidney
20. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs
21. Analgesic use and chronic renal disease
22. Nonsteroidal antiinflammatory drugs and risk of chronic renal disease
23. Nonsteroidal antiinflammatory drugs: differences and similarities
24. Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated sailcylates, and nonacetylated nonsteroidal antiinflammatory drugs
25. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons
26. Effect of non‐steroidal anti‐inflammatory drugs on the course of osteoarthritis
27. Cost conscious prescribing of nonsteroidal antiinflammatory drugs for adults with arthritis: a review and suggestions
28. Nonsteroidal antiinflammatory drug use and death from peptic ulcer in elderly persons
29. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract: the doubleedged sword
30. Renal effects of prostaglandins and clinical adverse effects of non‐steroidal anti‐inflammatory agents
31. Misoprostil: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti‐inflammatory drugs
32. The costeffectiveness of misoprostol for nonsteroidal antiinflammatory drug–associated adverse gastrointestinal events
33. Is misoprostil costeffective in the prevention of nonsteroidal antiinflammatory drug‐induced gastropathy in patients with chronic arthritis
34. Disease modifying antirheumatic drugs: current state of their application in animal models of osteoarthritis
35. Operative treatment of osteoarthritis: current practice and future development
36. Total Hip Replacement
37. Geographic variations in the rates of elective total hip and knee arthroplasties among Medicare beneficiaries in the United States
38. Relationship of surgical volume to short‐term mortality, morbidity, and hospital charges in arthroplasty